Cipla Asthalin HFA 100mcg Metered Dose Inhaler

Cipla Asthalin HFA 100mcg Metered Dose Inhaler contains salbutamol (albuterol) 100mcg per metered dose, a short-acting beta2-agonist (SABA) bronchodilator used for the quick relief of asthma and chronic obstructive pulmonary disease (COPD) symptoms such as wheezing, breathlessness, and chest tightness caused by narrowed airways. It is commonly known as a ‘reliever’ or ‘rescue’ inhaler because of its fast onset of action.

As an inhaled bronchodilator device, Cipla Asthalin HFA 100mcg Metered Dose Inhaler is generally supplied as a prescription item by most pharmacies in Malaysia, and DoctorOnCall requires an online consultation so a doctor can confirm the diagnosis, correct inhaler technique, and appropriate use before dispensing, particularly given the importance of using reliever inhalers correctly alongside any prescribed long-term asthma or COPD management.

Salbutamol selectively stimulates beta2-adrenergic receptors in the smooth muscle of the airways, causing the muscles around the bronchi to relax and the airways to widen (bronchodilation) within minutes, which relieves wheezing, breathlessness, and chest tightness associated with asthma and COPD flare-ups.

Shake the inhaler well before each use, breathe out fully away from the device, place the mouthpiece between your lips and form a tight seal, then press down on the canister while breathing in slowly and deeply; hold your breath for about 10 seconds before breathing out slowly. Prime the inhaler with test sprays into the air before first use or after a period of non-use, as instructed in the package leaflet.

For quick relief of symptoms, the usual adult dose is 1 to 2 puffs (100 to 200mcg) as needed, and for prevention of exercise-induced symptoms, 1 to 2 puffs shortly before exertion, but exact dosing, including maximum daily puffs, should follow your doctor’s instructions and the package leaflet; seek medical attention if you find yourself needing it more often than usual.

Cipla Asthalin HFA 100mcg Metered Dose Inhaler is generally stable for up to 24 to 36 months from manufacture when unopened and stored correctly; check the expiry date on the canister or carton and dispose of the inhaler once the labelled number of doses has been used or it has expired.

Store the inhaler below 30°C, away from direct heat, sunlight, and frost, and never puncture, break, or burn the canister even when it appears empty, as it remains pressurised; keep out of reach of children.

• Known hypersensitivity to salbutamol or any other ingredient in the inhaler
• Caution required in people with significant heart rhythm problems, uncontrolled heart disease, or thyrotoxicosis
• Not a substitute for anti-inflammatory (preventer) treatment in persistent asthma; overuse without proper monitoring can mask worsening disease
• Caution in people with poorly controlled diabetes, as beta2-agonists can affect blood glucose and potassium

• Beta-blockers may reduce the effectiveness of salbutamol and can trigger bronchospasm in susceptible individuals
• Other bronchodilators or stimulant medicines used together may increase the risk of tremor and palpitations
• Diuretics may increase the risk of low blood potassium when combined with salbutamol
• Certain antidepressants (MAOIs, tricyclics) may increase cardiovascular side effects

• Always carry your reliever inhaler with you, especially if you have known asthma or COPD
• Check the dose counter (if present) so you know when the inhaler is running low
• If you need your reliever inhaler more than usual, see your doctor as your regular treatment may need review
• Rinse your mouth after use if you notice throat irritation
• Have your inhaler technique checked periodically by your doctor or pharmacist to make sure you are getting the full dose

Cipla Asthalin HFA 100mcg Metered Dose Inhaler is intended for the quick relief of asthma and COPD symptoms rather than for long-term control, and increasing reliance on it can be a sign that your regular preventer therapy needs to be reviewed with your doctor.